Antifungal susceptibility profile
|
Resistant to FLU, cross-resistant to echinocandins and AMB, some are pan-resistant |
Lower resistance to antifungal agents |
Resistant to FLU, cross-resistant to echinocandins and AMB, some are pan-resistant |
Resistant to FLU, cross-resistant to echinocandins and AMB, some are pan-resistant |
Resistant to FLU, cross-resistant to echinocandins and AMB, some are pan-resistant |
Clinical isolation site
|
Ear, blood, or other invasive sites |
Mainly ear |
Ear, urine, blood, or other invasive sites |
Blood, or other invasive sites |
Nail, skin, ear |
Mating type
|
MTLa |
MTLα |
MTLα |
MTLa |
Not known |
ERG11 mutations
|
Y132F or K143F |
K143R, L43H, Q357K |
F126L |
Y132F, K143R, K177R, N335S, E343D |
Y132F, I466L |
TAC1B mutations
|
R495G, A640V, A657V, A15T, S195C, P595L |
F214S |
None |
F214S, F862_N866del, K247E, M653V, A651T, P595H |
Not known |
Outbreaks
|
Invasive infections |
Ear infections |
Invasive infections |
Invasive infections |
Invasive infections |
Geography
|
Dominates in the United States, Europe, South Asia |
Dominates in Korea, Japan |
Dominates in Europe, Africa |
Dominates in the United States |
Dominates in Iran |
Phenotypes
|
Growth on actidione |
No |
Yes |
Yes |
Not known |
Not known |
Pseudohyphae |
Yes |
No |
No |
Not known |
Not known |
Large cellular aggregates |
No |
Yes |
Yes |
Not known |
Not known |
Assimilation of L-rhamnose |
No |
No |
Yes |
No |
Yes |
Utilization of N-acetyl glucosamine |
Yes |
No |
Yes |
Yes |
Yes |